Callan Family Office’s ICL Group ICL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$351K Buy
70,429
+2,267
+3% +$12.9K 0.01% 942
2026
Q1
$351K Sell
68,162
-1,923
-3% -$10.3K 0.01% 875
2025
Q4
$403K Buy
70,085
+2,553
+4% +$14.8K 0.01% 841
2025
Q3
$423K Sell
67,532
-5,144
-7% -$33K 0.01% 586
2025
Q2
$499K Buy
72,676
+49,591
+215% +$324K 0.02% 587
2025
Q1
$130K Hold
23,085
0.01% 531
2024
Q4
$114K Buy
+23,085
New +$103K 0.01% 615

Other funds holding ICL

Callan Family Office's ICL Position: Q2 2026 in Review

Callan Family Office increased its ICL Group (ICL) stake by 3.3% in Q2 2026, buying an estimated $12.9K and bringing the position to 70,429 shares worth $351K. The position accounts for 0.01% of the portfolio, ranked #942.

Callan Family Office first reported a position in ICL in Q4 2024 and has held it in 7 quarters since. The position peaked at $499K in Q2 2025. 220 funds tracked by Wall St. Rank hold ICL as of Q2 2026.

  • Callan Family Office held 70,429 shares of ICL Group worth $351K as of Q2 2026.
  • Callan Family Office bought 2,267 ICL Group shares in Q2 2026, an estimated $12.9K.
  • ICL Group made up 0.01% of Callan Family Office's portfolio in Q2 2026, its #942 holding.
  • Callan Family Office first reported a position in ICL Group in Q4 2024 and has held it in 7 quarters since.
  • Callan Family Office's ICL Group position peaked at $499K in Q2 2025.
  • 220 funds tracked by Wall St. Rank held ICL Group as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.